| Authors: |
Tang G; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. Electronic address: gtang@mdanderson.org., Wang SA; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Jen WY; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Wang W; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Fang H; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Hu S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Jabbour EJ; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Zou YS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Xu J; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. |
